Lab Grown Diamond Market to Reach $59.2 billion, Globally, by 2032 at 9.6% CAGR: Allied Market Research

Increase in the adoption of lab grown diamonds in the fashion and jewelry sector along with increase in applications of these diamonds in the industrial sector have spurred the demand for lab grown diamonds across myriad industry verticals. These lab grown diamonds can also be customized and personalized as per requirement, which further adds advantages […]

Tongcheng Travel Reports 2025 Third Quarter Results Tapping Further into Mass Travel Market Yields Solid Growth of Core OTA Business

Strategic Acquisition of High-end Hotel Brand to Extend Industry Profile Mass Travel Demand Drives User Base to New Historic High Twelve-month Accumulated Number of Travelers Served Surpasses 2 Billion Tongcheng Travel Holdings Limited (“Tongcheng Travel” or the “Company”, together with its subsidiaries the “Group”, stock code: 0780.HK), aleading comprehensive travel platform in China, today announced

Sitka Drills 172.4 Metres of 0.90 g/t Gold, Including 33.4 Metres of 2.40 g/t Gold, at Blackjack and 44.4 Metres of 1.33 g/t Gold from Surface at Saddle at Its RC Gold Project, Yukon

Drill hole DDRCCC-25-099 intersected 310.0 m of 0.61 g/t Au, including 172.4 m of 0.90 g/t Au, 26.8 m of 1.04 g/t Au, and 33.4 m of 2.40 g/t Au further expanding the Blackjack Deposit. Drill hole DDRCCC-25-102 intersected 191.8 m of 0.65 g/t Au including 119.9 m of 0.87 g/t Au and 24.3 m

Aramco Ventures to Open New Office in Paris, Expanding Global Innovation Footprint

Aramco Ventures, the venture capital arm of Aramco, today announced plans to open a new office in Paris, France, in 2026. The expansion underscores Aramco's growing commitment to global innovation, as the company continues to invest in next-generation technologies that support its long-term strategy for business diversification and energy transformation. With over $7 billion in

COMEUP 2025: Recode the Future – Officially Launched in Seoul

— A Global Startup Festival Co-hosted by the Ministry ofSMEs and Startups (MSS) and Korea Startup Forum (KSF) — From December 10-12 at COEX Seoul, the three-day festival will bring together innovative startups, global and domestic investors, and major corporation — A wide range of programs – including conferences, exhibitions, IR pitching, business matchmaking, and

DigiCert Selected by Jisc to Advance Digital Trust Across UK Education and Research

DigiCert Selected by Jisc to Advance Digital Trust Across UK Education and Research Jisc's national framework gives member institutions streamlined access to DigiCert's trusted security solutions without the need for separate procurement GlobeNewswire November 25, 2025 London, UK, Nov. 25, 2025 (GLOBE NEWSWIRE) — DigiCert, a global leader in intelligent trust, has been selected by

TÜV Rheinland and NETEC Announce Technical Cooperation to Support Fire Door Compliance for Singapore Market

TÜV Rheinland, an independent global provider of testing, inspection, and certification services, has signed a cooperation agreement with the National Elevator Inspection and Testing Centre (NETEC). The agreement focuses on coordinated fire door testing for the Singapore market and was formalized at a ceremony in Langfang, Hebei Province. Under the agreement, TÜV Rheinland recognizes NETEC's

PONY AI Inc. Realized Gen-7 Robotaxi city-wide UE Breakeven; Set to Surpass 2025 Fleet Target and Expand to 3,000+ Vehicles by End of Next Year

(NASDAQ:PONY),(HKSE:2026.HK), Successful dual primary listing in Hong Kong — Raised more than US$800 million1 to accelerate mass production, large-scale commercialization, R&D innovation and new market expansion. Official launch of Gen-7 Robotaxi operations — Kicked off fully driverless commercial operations in Guangzhou, Shenzhen, and Beijing. Continued progress in Robotaxi commercialization — Robotaxi revenues up by 89.5%

NICE Recommends AUCATZYL(R) (obecabtagene autoleucel) as a Treatment Option for Adult Patients (greater-than or equal to26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1)

(NASDAQ:AUTL), LONDON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the National Institute for Health and Care Excellence (NICE) has published draft guidance1 recommending AUCATZYL(R) (obecabtagene autoleucel, or “obe-cel”)2 for use in the National Health Service

Scroll to Top